BusinessVBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMay 1, 2018, 12:01 PM UTC
BusinessVBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) PatientsBy Nasdaq OMXApr 17, 2018, 12:01 PM UTC
BusinessInspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid StentBy Nasdaq OMXJan 19, 2018, 3:18 PM UTC
BusinessLexington Completes IRB Submission in Preparation for Clinical StudyBy Nasdaq OMXJan 18, 2018, 2:01 PM UTC
BusinessVitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THCBy Nasdaq OMXJan 3, 2018, 1:31 PM UTC
BusinessVBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B VaccineBy Nasdaq OMXDec 19, 2017, 1:00 PM UTC
BusinessAmarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Covering Treatment of Parkinson’s LIDBy Nasdaq OMXDec 8, 2017, 3:27 PM UTC
